Negative pressure wound therapy (NPWT) has become one of the most widely used adjunctive treatments in diabetic foot care, yet it is also one of the most inconsistently applied. Some wounds respond dramatically; others show little benefit and the therapy simply adds cost and complexity. Understanding what the evidence actually supports — and, equally important, where it remains uncertain — helps clinicians and patients decide when a vacuum device belongs on a diabetic foot wound.
How Negative Pressure Wound Therapy Works
NPWT applies controlled sub-atmospheric pressure across a wound through a foam or gauze filler sealed under a semi-occlusive drape and connected to a suction pump. Normandin and colleagues, writing in Seminars in Plastic Surgery (2021), describe four principal mechanisms: macrodeformation, in which the collapsing foam draws wound edges together; removal of extracellular inflammatory fluid and exudate; stabilisation of the wound environment, including temperature and moisture; and microdeformation at the foam–tissue interface, which produces cellular strain that stimulates angiogenesis and granulation tissue formation.
These mechanisms explain why NPWT tends to perform best on deep, cavitary, heavily exudative wounds — the post-debridement or post-amputation defect rather than the shallow neuropathic plantar ulcer. Newer variants, including NPWT with instillation and dwell time (NPWTi-d), add periodic delivery of a topical solution to the wound bed between suction cycles, broadening the range of wounds for which the technology has been trialled.
What the Randomised Evidence Shows
The most rigorous synthesis remains the Cochrane review by Liu and colleagues (2018), which pooled eleven randomised controlled trials involving 972 participants. For post-operative foot wounds — largely post-amputation defects — NPWT increased the proportion of wounds healed compared with moist dressings (risk ratio 1.44, 95% CI 1.03 to 2.01) and shortened median time to healing by roughly three weeks. For diabetic foot ulcers, pooled data from five trials (486 participants) again favoured NPWT for the proportion of wounds healed (RR 1.40, 95% CI 1.14 to 1.72), and three trials totalling 441 participants suggested a reduced risk of amputation (RR 0.33, 95% CI 0.15 to 0.70). Critically, the review authors graded all of these findings as low-certainty evidence, downgraded for risk of bias and imprecision.
Subsequent meta-analyses have reached broadly similar conclusions. Chen and colleagues (Annals of Palliative Medicine, 2021) pooled nine randomised trials of 943 patients and found significantly higher healing rates with NPWT and markedly faster granulation tissue formation, with no excess of adverse events; the reduction in amputation did not reach statistical significance in their analysis. A 2024 meta-analysis by Monami and colleagues in Acta Diabetologica, prepared to support the Italian diabetic foot guidelines, examined eight NPWT trials among 51 studies of adjuvant therapies. NPWT was associated with a higher ulcer healing rate and shorter time to healing, but the quality of evidence for NPWT was rated only moderate — lower than for skin substitutes, growth factors or hyperbaric oxygen — and NPWT did not significantly reduce major amputation.
Where Guidelines Have Landed
The 2023 IWGDF guideline on interventions to enhance healing, authored by Chen, Game and colleagues, reflects this nuance. Among 29 recommendations, the group issued a conditional recommendation supporting NPWT specifically for post-operative diabetes-related foot wounds — not as a general treatment for all foot ulcers. As with every adjunctive therapy in that guideline, the recommendation is conditioned on best standard of care having been delivered first: adequate debridement, infection control, assessment and treatment of ischaemia, and effective offloading. NPWT does not substitute for any of these.
A Practical Role: Wound Bed Preparation
One of the clearest applications is preparing a wound for surgical closure. In a randomised trial of 100 patients with chronic diabetic foot ulcers published in the Saudi Medical Journal (2023), Wu and colleagues compared NPWT with alginate dressings before split-thickness skin grafting. Patients treated with NPWT reached graft surgery sooner, showed higher graft survival rates, and had greater wound blood perfusion. The investigators also documented biological changes consistent with the mechanistic literature — reduced neutrophil extracellular trap formation and a shift in wound macrophages from the pro-inflammatory M1 phenotype toward the reparative M2 phenotype.
A 2024 systematic review by Dalmedico and colleagues in Wounds reported comparable findings across 13 randomised trials, with NPWT superior for wound area reduction in eight of ten comparisons, while noting substantial clinical heterogeneity and methodological limitations across the included studies.
Clinical Summary
NPWT accelerates granulation, reduces wound volume and prepares wounds for closure, and it is generally safe when applied with appropriate pressure settings and monitoring for bleeding. Its strongest evidence lies in post-operative and post-amputation foot wounds and in wound bed preparation before grafting. Its weakest evidence lies in claims of amputation prevention, where confidence intervals remain wide and trial quality modest. The technology is an adjunct layered onto — never a replacement for — debridement, revascularisation where indicated, infection management and mechanical offloading. Clinicians selecting NPWT for a diabetic foot wound are on firmest ground when the wound is deep, exudative, recently debrided, and adequately perfused.
References
- Liu Z, Dumville JC, Hinchliffe RJ, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus. Cochrane Database of Systematic Reviews. 2018;10:CD010318.
- Chen P, Vilorio NC, Dhatariya K, et al. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diabetes/Metabolism Research and Reviews. 2024;40(3):e3644.
- Monami M, Scatena A, Ragghianti B, et al. Effectiveness of most common adjuvant wound treatments for the management of hard-to-heal diabetic foot ulcers: a meta-analysis of randomized controlled trials. Acta Diabetologica. 2025;62(7):1081–1095.
- Chen L, Zhang S, Da J, et al. A systematic review and meta-analysis of efficacy and safety of negative pressure wound therapy in the treatment of diabetic foot ulcer. Annals of Palliative Medicine. 2021;10(10):10830–10839.
- Normandin S, Safran T, Winocour S, et al. Negative pressure wound therapy: mechanism of action and clinical applications. Seminars in Plastic Surgery. 2021;35(3):164–170.
- Wu Y, Shen G, Hao C. Negative pressure wound therapy is superior to conventional moist dressings in wound bed preparation for diabetic foot ulcers: a randomized controlled trial. Saudi Medical Journal. 2023;44(10):1020–1029.
- Dalmedico MM, Fedalto AR, Martins WA, et al. Effectiveness of negative pressure wound therapy in treating diabetic foot ulcers: a systematic review and meta-analysis of randomized controlled trials. Wounds. 2024;36(8):281–289.
Comments
